Colgate-Palmolive (CL) January 31 weekly 90 straddle priced into quarter results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/8/2026
- S&P 500 falls as AI worries hit software makers
- Brent crude hits six-week high near $97 as Houthi strike targets Saudi Aramco
- Qualcomm stock surges 9.5% on Amazon AI deal & 25M share warrant
- Energy stocks rise premarket as oil prices climb on Middle East supply fears
- Novartis shares plunge 10% as failed drug trial clouds growth outlook
- Harry and Meghan surprised by King Charles' letter on their status
- Citi initiates UiPath coverage with Buy rating and $23 target
- S&P 500 falls as AI worries hit software makers
- WestPark Capital Starts Akebia Therapeutics (AKBA) at Buy
- After an 18% summer selloff in chip stocks, Citi asks what comes next
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
- After-Hours Movers: NVDA, CRM, SNPS, CRWD, OKTA, NTNX
TD Cowen Reiterates Buy Rating on Colgate-Palmolive Company (CL)
February 3, 2025 1:18 PM ESTTD Cowen analyst Robert Moskow reiterated a Buy rating and $100.00 price target on Colgate-Palmolive Company (NYSE: CL).
The analyst comments "4Q gross margin expanded 70 bps, materially slower than the 290 bps in the last three quarters, because the transactional FX amplified cost inflation and... More
Barclays Reiterates Equalweight Rating on Colgate-Palmolive Company (CL)
February 3, 2025 6:49 AM ESTBarclays analyst Lauren R. Lieberman reiterated an Equalweight rating and $83.00 price target on Colgate-Palmolive Company (NYSE: CL)
The analyst comments "Given Colgate's greater exposure to emerging markets (~50% of total company sales), it has benefited disproportionately versus its Staples peers, from inflationary pricing (a ~10.5%... More
Raymond James Reiterates Outperform Rating on Colgate-Palmolive Company (CL)
January 31, 2025 8:50 AM ESTRaymond James analyst Olivia Tong reiterated an Outperform rating and $110.00 price target on Colgate-Palmolive Company (NYSE: CL)
The analyst comments "CL reported 4Q results this morning, and while organic sales and margins missed, below-the-line expenses were lower than expected, resulting in an EPS beat ($0.91 vs. our $0.90 and StreetAccount/BBG consensus $0.89). Organic sales... More
